Post-treatment alterations in 18F-dihydrotestosterone (FDHT) and FDG PET/CT in metastatic castration-resistant prostate cancer (mCRPC) treated with cabozantinib Meeting Abstract


Authors: Fox, J. J.; Haupt, E. C.; Humm, J.; Autio, K. A.; Rathkopf, D. E.; Vargas, H. A.; Schöder, H.; Hricak, H.; Larson, S. M.; Scher, H. I.; Morris, M. J.
Abstract Title: Post-treatment alterations in 18F-dihydrotestosterone (FDHT) and FDG PET/CT in metastatic castration-resistant prostate cancer (mCRPC) treated with cabozantinib
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419601671
PROVIDER: wos
Notes: Meeting Abstract: 5073 -- Source: Wos
MSK Authors
  1. Josef J Fox
    44 Fox
  2. Michael Morris
    274 Morris
  3. Karen Anne Autio
    40 Autio
  4. Heiko Schoder
    285 Schoder
  5. Dana Elizabeth Rathkopf
    142 Rathkopf
  6. Hedvig Hricak
    330 Hricak
  7. John Laurence Humm
    339 Humm
  8. Steven M Larson
    762 Larson
  9. Howard Scher
    816 Scher
  10. Eric C Haupt
    5 Haupt